Arrhythmia: Types, Causes, Symptoms, and Treatment

An arrhythmia is an abnormality in the heart’s rate, rhythm, origin of electrical impulses, or conduction of those impulses through the cardiac conduction system. Some arrhythmias are mild and cause little physiologic disturbance, while others can reduce cardiac output, impair tissue perfusion, or progress rapidly to cardiac arrest.

Accurate recognition depends on understanding normal sinus rhythm and evaluating the electrocardiogram (ECG) systematically.

Important findings include heart rate, rhythm regularity, P-wave appearance, PR interval, QRS duration, and the relationship between atrial and ventricular electrical activity.

What Is an Arrhythmia?

An arrhythmia, also called a dysrhythmia, occurs when the heart’s normal electrical activity becomes abnormal. The disturbance may involve how quickly electrical impulses are generated, where those impulses originate, how regularly they occur, or how they travel through the conduction system.

Normal cardiac electrical activity begins in the sinoatrial (SA) node, spreads through the atria, travels through the atrioventricular (AV) node, and then passes into the ventricles through the normal conduction pathways. Any disruption in impulse formation or conduction can alter the heart rhythm.

Arrhythmias can cause the heart to beat:

• Too quickly
• Too slowly
• Irregularly
• From an abnormal electrical focus
• With delayed or blocked conduction between the atria and ventricles

The clinical importance of an arrhythmia depends on its type, duration, effect on cardiac output, and the patient’s underlying condition. A rhythm that is tolerated by one patient may cause significant hemodynamic instability in another.

Understanding Normal Sinus Rhythm

Normal sinus rhythm is the standard against which abnormal rhythms are compared. The electrical impulse originates in the SA node and follows the normal conduction pathway through the atria and ventricles.

Normal sinus rhythm generally has the following characteristics:

• Heart rate of 60 to 100 beats/min in a resting adult
• Regular R-R intervals
• Upright and uniform P waves
• One P wave before every QRS complex
• One QRS complex after every P wave
• Constant PR interval between 0.12 and 0.20 second
• QRS duration of 0.12 second or less
• Flat ST segment under normal conditions

Changes in these features may indicate an abnormal rhythm or conduction disturbance.

Heart rate can also be estimated from the ECG by examining the distance between R waves. At the standard ECG recording speed, one large box represents 0.20 second. For regular rhythms, dividing 300 by the number of large boxes between consecutive R waves gives an approximate heart rate.

For example, three large boxes between R waves correspond to approximately 100 beats/min.

How Arrhythmias Are Evaluated

Accurate rhythm interpretation requires a systematic approach rather than focusing only on whether the heart rate is fast or slow. The entire tracing should be evaluated.

Important features include:

• Heart rate
• Regularity of the rhythm
• P-wave presence and appearance
• P-P interval
• R-R interval
• PR interval
• QRS width and morphology
• QT interval
• ST segment
• T waves
• Relationship between atrial and ventricular activity

The ECG must also be interpreted together with the patient’s clinical condition. An organized electrical rhythm does not guarantee that the heart is producing an effective mechanical contraction or adequate circulation.

Assessment should therefore include the patient’s pulse, blood pressure, oxygenation, respiratory status, level of consciousness, skin condition, peripheral perfusion, and overall hemodynamic stability.

Major Types of Arrhythmias

Arrhythmias can be organized according to the area of the heart in which the electrical disturbance originates.

Major categories include:

• Sinus arrhythmias
• Atrial arrhythmias
• Atrioventricular conduction blocks
• Ventricular arrhythmias
• Cardiac arrest rhythms

Note: Each category produces characteristic changes on the ECG and has different clinical implications.

Sinus Arrhythmias

Sinus arrhythmias originate in the SA node. The normal conduction pathway remains intact, but the rate or timing of impulse formation becomes abnormal.

Sinus Tachycardia

Sinus tachycardia occurs when the SA node generates impulses faster than normal. In an adult, the resting heart rate exceeds 100 beats/min while the impulse continues to follow the normal conduction pathway.

The ECG generally shows normal P waves, normal PR intervals, and normal QRS complexes. Each P wave is followed by a QRS complex.

Common causes include:

• Hypoxemia
• Fever
• Pain
• Anxiety
• Hypovolemia
• Hypotension
• Increased metabolic activity
• Trauma
• Caffeine
• Certain medications
• Patient-ventilator asynchrony
• Difficulty during ventilator weaning

Sinus tachycardia is often a physiologic response to another problem rather than a primary cardiac disorder. Treatment is therefore directed primarily at the underlying cause.

For example, hypoxemia may require improved oxygenation, fever may require antipyretic therapy, hypovolemia may require fluid replacement, and pain should be treated appropriately.

Sinus Bradycardia

Sinus bradycardia is a sinus rhythm with a heart rate below 60 beats/min. Electrical impulses still originate from the SA node, and the ECG complexes may otherwise appear normal.

Sinus bradycardia can occur normally in well-trained athletes because an increased stroke volume allows adequate cardiac output despite the slower rate.

Other causes include:

• Hypothermia
• SA-node dysfunction
• Cardiac disease
• Severe or chronic hypoxemia
• Increased intracranial pressure
• Obstructive sleep apnea
• Beta blockers
• Digitalis
• Morphine
• Cardiopulmonary arrest

The clinical significance depends on whether adequate perfusion is maintained. Severe bradycardia may reduce cardiac output and blood pressure, resulting in weak pulses, delayed capillary refill, cool clammy skin, tissue hypoxia, altered mental status, or syncope.

Symptomatic bradycardia may require atropine or cardiac pacing. The underlying cause should also be identified and corrected whenever possible.

Sinus Arrhythmia

Sinus arrhythmia is characterized by variation in the R-R intervals while the remaining features of the ECG remain generally normal. The rhythm often varies with respiration.

During spontaneous inspiration, heart rate may increase, causing the QRS complexes to move closer together. During expiration, the rate decreases.

This occurs because changes in intrathoracic pressure and venous return influence cardiac filling and autonomic control. Sinus arrhythmia is usually benign and does not require treatment.

Atrial Arrhythmias

Atrial arrhythmias originate from abnormal electrical activity within the atria rather than from the SA node. They include premature atrial contractions, atrial tachycardia, atrial flutter, and atrial fibrillation.

Premature Atrial Contractions

A premature atrial contraction occurs when an abnormal atrial focus generates an impulse earlier than expected in the cardiac cycle.

Isolated premature atrial contractions may occur without serious consequences. When premature atrial impulses occur repeatedly, they may form patterns such as atrial bigeminy or contribute to more persistent atrial arrhythmias.

Paroxysmal Atrial Tachycardia

Paroxysmal atrial tachycardia, sometimes described as paroxysmal supraventricular tachycardia, originates from an abnormal atrial focus. It typically consists of three or more consecutive premature atrial impulses and may produce heart rates between approximately 140 and 250 beats/min.

Because ventricular conduction often remains intact, the QRS complexes may appear relatively normal.

Patients may experience:

• Rapid pounding heartbeat
• Fluttering in the chest
• Weakness
• Shortness of breath
• Angina
• Reduced exercise tolerance

Note: Short episodes may be tolerated, but prolonged episodes may decrease cardiac output and require treatment. Management may include vagal stimulation, medications that slow conduction or heart rate, and synchronized cardioversion when appropriate.

Atrial Flutter

Atrial flutter is caused by rapid, organized atrial electrical activity, commonly occurring at approximately 250 to 350 beats/min. The atria contract much faster than the ventricles. Because the AV node cannot conduct every atrial impulse, conduction ratios such as 2:1, 3:1, or 4:1 may occur.

The ECG classically demonstrates flutter waves with a sawtooth appearance between QRS complexes.

Treatment depends on the ventricular response and the patient’s clinical condition. Management may involve medications that slow AV conduction, rhythm-control therapy, or synchronized cardioversion.

Atrial Fibrillation

Atrial fibrillation results from disorganized electrical activity originating from multiple atrial sites. Normal P waves disappear and are replaced by irregular fibrillatory activity. Ventricular conduction is inconsistent, producing an irregular ventricular rhythm.

Typical findings include:

• No normal P waves
• Irregular R-R intervals
• Variable atrial electrical activity
• Irregular ventricular response

One of the most important consequences is the loss of coordinated atrial contraction. When the atria do not empty effectively, blood may stagnate and form thrombi. These thrombi may later become emboli and travel through the circulation, creating the potential for serious complications.

Management may involve control of the ventricular rate, restoration of sinus rhythm when appropriate, and anticoagulation to reduce the risk of thrombus formation.

Atrioventricular Heart Blocks

AV blocks occur when conduction between the atria and ventricles becomes delayed or interrupted. Potential causes include myocardial infarction, medication effects, digitalis toxicity, arteriosclerosis, inflammation, edema, and scarring within the conduction system.

First-Degree AV Block

First-degree AV block occurs when conduction through the AV system is delayed but not interrupted. The major ECG finding is a PR interval greater than 0.20 second.

Every P wave is still followed by a QRS complex, showing that each atrial impulse eventually reaches the ventricles. The rhythm is often stable, and treatment is usually unnecessary when cardiac output and blood pressure remain adequate.

Second-Degree AV Block

Second-degree AV block occurs when some atrial impulses fail to reach the ventricles. There are two major forms.

Mobitz Type I

Mobitz type I, also called Wenckebach, is characterized by progressive lengthening of the PR interval until one atrial impulse fails to conduct and a QRS complex is dropped.

After the dropped beat, the cycle repeats. This pattern is often less dangerous than Mobitz type II and may be transient.

Mobitz Type II

Mobitz type II is more serious. Some P waves are not followed by QRS complexes, but the PR intervals of conducted beats do not progressively lengthen before the dropped beat.

This pattern indicates more significant conduction-system disease and may progress to complete heart block. Cardiac pacing may be required.

Third-Degree AV Block

Third-degree AV block, or complete heart block, occurs when atrial impulses no longer conduct to the ventricles. The atria continue to be paced by the SA node, while the ventricles are controlled by an independent escape pacemaker.

The atrial and ventricular rhythms therefore have no consistent relationship.

Typical findings include:

• Regular P-P intervals
• Regular R-R intervals
• No consistent relationship between P waves and QRS complexes
• Ventricular rate slower than the atrial rate
• No measurable constant PR interval

If the ventricular pacemaker arises near the bundle of His, the ventricular rate may be approximately 40 to 60 beats/min. If it originates lower in the ventricles, the rate may fall to approximately 20 to 40 beats/min.

Complete heart block can significantly reduce cardiac output and may cause syncope, hypotension, poor exercise tolerance, or other signs of inadequate perfusion. A pacemaker is generally required.

Premature Ventricular Contractions

Premature ventricular contractions (PVCs) originate from abnormal electrical activity within the ventricles. Because depolarization does not follow the normal conduction pathway, the QRS complex usually appears premature, wide, and abnormal compared with the patient’s normal beats.

Common findings include:

• Premature QRS complex
• QRS duration greater than 0.12 second
• Abnormal QRS morphology
• No normal P wave immediately before the PVC
• Compensatory pause following the premature beat
• T wave that may deflect opposite the QRS complex

PVCs may be uniform or multiform and may occur as isolated beats, pairs, bigeminy, or trigeminy.

Potential causes include:

• Hypoxemia
• Myocardial ischemia
• Acidosis
• Electrolyte disturbances
• Anxiety
• Caffeine
• Tobacco
• Alcohol
• Beta-agonists
• Theophylline
• Digitalis
• Catecholamines

Multifocal PVCs are especially concerning because they indicate multiple areas of ventricular irritability.

PVCs occurring very early during ventricular repolarization may also be dangerous. A PVC that falls on the preceding T wave is known as the R-on-T phenomenon and may trigger ventricular tachycardia.

Ventricular Tachycardia

Ventricular tachycardia (VT) is generally defined as three or more consecutive ventricular beats originating from the ventricles. The rhythm may range from approximately 100 to 250 beats/min depending on the specific presentation.

Typical findings include:

• Rapid ventricular rate
• Wide QRS complexes
• Abnormal QRS morphology
• Difficult-to-identify P waves
• Reduced ventricular filling time
• Decreased cardiac output

VT may be brief or sustained. The patient’s pulse and hemodynamic status are critical when deciding how serious the rhythm is and what treatment is required. A patient with sustained VT may develop hypotension, altered mental status, pulmonary edema, syncope, or cardiac arrest.

Stable VT may be treated with antiarrhythmic medications such as amiodarone or other appropriate agents. Unstable VT with a pulse may require synchronized cardioversion. Pulseless VT is a cardiac-arrest rhythm requiring immediate CPR and defibrillation.

Ventricular Flutter

Ventricular flutter is an extremely rapid ventricular rhythm, often occurring at approximately 250 to 350 beats/min. QRS complexes become poorly defined, normal atrial activity may not be visible, and a peripheral pulse is often absent.

This rhythm is highly unstable and frequently deteriorates into ventricular fibrillation. Immediate emergency treatment is required.

Ventricular Fibrillation

Ventricular fibrillation (VF) is chaotic ventricular electrical activity that prevents coordinated ventricular contraction. The ventricles no longer pump blood effectively, resulting in the absence of meaningful cardiac output.

The patient is pulseless and has no effective blood pressure. VF is a cardiac-arrest rhythm that requires immediate intervention.

Management includes:

• Recognition of cardiac arrest
• Immediate high-quality CPR
• Rapid defibrillation
• Advanced cardiovascular life-support measures
• Identification of reversible causes

Note: Without rapid treatment, cerebral hypoxia and death can occur within minutes.

Pulseless Electrical Activity

Pulseless electrical activity (PEA) occurs when organized electrical activity is visible on the ECG but no effective mechanical cardiac contraction produces a palpable pulse. PEA demonstrates why clinicians must never treat the cardiac monitor alone. A rhythm that appears organized does not prove that circulation is present.

The patient must always be assessed directly for a pulse, blood pressure, consciousness, oxygenation, and other signs of perfusion. PEA is treated with immediate CPR and correction of reversible causes rather than routine defibrillation.

Asystole

Asystole represents the absence of effective ventricular electrical activity. The patient has no pulse and no effective cardiac output.

Like PEA, asystole is a nonshockable cardiac-arrest rhythm. Management involves high-quality CPR, advanced life-support measures, and identification and correction of reversible causes.

Common Causes of Arrhythmias

Arrhythmias can develop from abnormalities involving the heart itself or from broader cardiopulmonary and metabolic problems.

Important contributing factors include:

• Myocardial ischemia
• Myocardial infarction
• Congestive heart failure
• Hypoxemia
• Hypercapnia
• Acid-base disturbances
• Electrolyte abnormalities
• Hypothermia
• Increased catecholamine activity
• Medications
• Stimulants
• Structural heart disease
• Abnormal conduction-system function

Note: Because the heart is sensitive to oxygen delivery, electrolyte concentrations, acid-base balance, and autonomic stimulation, systemic abnormalities can produce or worsen rhythm disturbances.

Electrolyte Abnormalities and Arrhythmias

Electrolyte disturbances are important reversible causes of abnormal cardiac rhythms. Potassium is especially important because it plays a major role in myocardial depolarization and repolarization.

Hypokalemia may contribute to PVCs and other arrhythmias. ECG changes can include ST-segment depression, flattened or inverted T waves, and prominent U waves. Hyperkalemia may produce tall T waves and widening of the QRS complex.

Certain respiratory medications, including beta-agonists such as albuterol, may lower serum potassium and contribute to arrhythmias in susceptible patients. Calcium and other electrolytes may also affect cardiac conduction and contractility. Unexplained arrhythmias may therefore require evaluation of serum electrolytes.

Respiratory Problems and Arrhythmias

Respiratory and cardiovascular function are closely connected. Hypoxemia, hypercapnia, acidosis, pulmonary disease, and changes in intrathoracic pressure can all influence cardiac rhythm.

Hypoxemia is particularly important because inadequate oxygen delivery can irritate the myocardium and contribute to tachycardia, PVCs, and more serious ventricular rhythms. If a new arrhythmia develops during a respiratory procedure, the clinician should assess oxygenation, ventilation, blood pressure, and the patient’s overall condition.

Arrhythmias During Mechanical Ventilation

Arrhythmias may occur in mechanically ventilated patients as part of broader cardiovascular instability. Positive-pressure ventilation increases intrathoracic pressure. Excessive airway pressure or lung volume can reduce venous return to the heart, potentially lowering cardiac output and blood pressure.

Complications associated with mechanical ventilation can include:

• Hypotension
• Decreased cardiac output
• Arrhythmias
• Barotrauma
• Oxygen toxicity
• Bronchopleural fistula

Note: An arrhythmia occurring together with hypotension, hypoxemia, or poor perfusion should be interpreted as part of a broader deterioration in cardiopulmonary status.

Suctioning and Arrhythmias

Endotracheal suctioning can also provoke cardiac rhythm changes. Prolonged suctioning may cause hypoxemia, bradycardia, and arrhythmias. For this reason, suctioning should not be unnecessarily prolonged, and the patient’s heart rhythm and oxygenation should be monitored throughout the procedure.

Arrhythmias During Ventilator Weaning

Cardiovascular stability is important when determining whether a patient is ready to wean from mechanical ventilation. As ventilatory support is reduced, the patient must assume a greater portion of the work of breathing. This increases oxygen consumption and places additional demands on the cardiovascular system.

Arrhythmias can interfere with successful weaning because they may limit cardiac output and oxygen delivery.

Other factors that may contribute to weaning failure include:

• Abnormal blood pressure
• Reduced cardiac output
• Fluid imbalance
• Anemia
• Acid-base disturbances
• Electrolyte abnormalities

Note: During a spontaneous breathing trial, arrhythmias may indicate that the patient is not tolerating the increased workload. Other signs of intolerance may include tachycardia, tachypnea, hypoxemia, hypertension, hypotension, acidosis, diaphoresis, agitation, and increased work of breathing.

Arrhythmias in Neonates and Children

Arrhythmias may also occur during the neonatal period and childhood. Approximately 1% to 5% of newborns may demonstrate some form of abnormal heart rate or rhythm during the first several days of life. Many are temporary and benign.

A normal neonatal heart rate is generally around 120 to 170 beats/min, although substantial variation can occur depending on gestational age, sleep, activity, pain, illness, and stimulation.

Note: A healthy infant may have a considerably slower rate during deep sleep and a much faster rate while crying or distressed.

Premature Atrial Contractions in Newborns

Premature atrial contractions are relatively common in newborns and may appear clinically as irregular or dropped beats. Many resolve without treatment.

However, persistent or severe rhythm disturbances should be evaluated with an ECG to determine the source and pattern.

Bradycardia and Apnea

Bradycardia is especially important in neonatal respiratory care because it may accompany apnea. Apnea of prematurity can produce hypoxemia and slowing of the heart rate.

When apnea becomes prolonged or severe, ventilatory support may be necessary. This demonstrates that neonatal bradycardia may be caused by respiratory dysfunction rather than by a primary cardiac abnormality.

Other Pediatric Causes

Potential contributors to pediatric arrhythmias include:

• Hypoxemia
• Acidosis
• Electrolyte disturbances
• Hypothermia
• Congenital cardiac disease
• Myocardial dysfunction
• Sepsis
• Central venous catheter placement

Note: A central venous catheter advanced too close to or into cardiac structures may irritate the myocardium and provoke arrhythmias. Careful positioning and radiographic confirmation are therefore important.

Hypothermia and Cardiac Rhythm

Severe hypothermia can profoundly affect cardiac electrical activity. As body temperature falls, heart rate and respiratory rate may slow significantly. Severe hypothermia may lead to bradycardia, ventricular arrhythmias, prolonged ECG intervals, ventricular fibrillation, or cardiac arrest.

The myocardium can also become extremely irritable. Excessive movement of a severely hypothermic patient may trigger an arrhythmia, so unnecessary manipulation should be avoided. Continuous cardiac monitoring is important during rewarming.

Medications Used to Treat Arrhythmias

Antiarrhythmic medications alter cardiac electrical activity to suppress abnormal rhythms, slow conduction, or maintain a more stable rhythm.

One commonly used classification system divides antiarrhythmic agents into Classes I, II, III, and IV. Some drugs have more than one electrophysiologic effect.

An important concern with any antiarrhythmic medication is proarrhythmia, which occurs when a medication intended to treat one rhythm disturbance causes or worsens another.

Class I Antiarrhythmics

Class I medications primarily block sodium channels.

Examples include:

• Quinidine
• Procainamide
• Disopyramide
• Lidocaine
• Mexiletine
• Flecainide
• Propafenone

Lidocaine is used primarily for ventricular arrhythmias and may be given intravenously. Procainamide may also be used for serious ventricular tachycardia.

These medications require careful monitoring because adverse effects may include hypotension, conduction abnormalities, neurologic symptoms, and proarrhythmia.

Class II Antiarrhythmics

Class II medications are beta blockers.

Examples include:

• Propranolol
• Metoprolol
• Atenolol
• Nadolol
• Esmolol
• Acebutolol

Beta blockers reduce sympathetic stimulation, slow heart rate, and decrease AV-node conduction. They may be used for rate control in atrial fibrillation or atrial flutter and for certain supraventricular tachycardias.

Potential adverse effects include bradycardia, AV block, reduced ventricular function, and bronchoconstriction.

Class III Antiarrhythmics

Class III medications affect repolarization and prolong the cardiac action potential.

Examples include:

• Amiodarone
• Dronedarone
• Dofetilide
• Sotalol
• Ibutilide

Note: Amiodarone is commonly used for both supraventricular and ventricular arrhythmias. These medications may produce significant adverse effects, including bradycardia, heart failure, QT prolongation, and dangerous ventricular arrhythmias. Electrolytes should be maintained within appropriate ranges during therapy.

Class IV Antiarrhythmics

Class IV medications are calcium-channel blockers. Verapamil and diltiazem slow conduction through the AV node and may be used for supraventricular arrhythmias and ventricular rate control in atrial fibrillation.

Potential adverse effects include bradycardia, AV block, and negative effects on cardiac contractility.

Digoxin and Adenosine

Digoxin slows conduction through the AV node and increases vagal influence on the heart. It may be used in selected patients for ventricular rate control, particularly when heart failure is also present.

However, digoxin toxicity can itself cause serious arrhythmias. Adenosine is commonly used to terminate certain supraventricular tachycardias. It has an extremely short duration of action and must be administered rapidly. Potential adverse effects include flushing, chest discomfort, dyspnea, cough, and bronchospasm.

Cardioversion and Defibrillation

Electrical therapy may be necessary when an arrhythmia causes significant hemodynamic compromise or cardiac arrest.

• Synchronized cardioversion delivers an electrical shock timed to the cardiac cycle and may be used for certain unstable tachyarrhythmias when the patient still has a pulse.
• Defibrillation delivers an unsynchronized electrical shock and is used for ventricular fibrillation and pulseless ventricular tachycardia.

Note: The distinction is important because not every abnormal rhythm should be shocked. Pulseless electrical activity and asystole are not treated with routine defibrillation.

Catheter Ablation

Radiofrequency catheter ablation may be used when an arrhythmia originates from an identifiable abnormal electrical circuit or focus. A catheter is advanced into the heart, and radiofrequency energy is used to destroy a small area of tissue responsible for generating or maintaining the abnormal rhythm.

This approach may be used in selected patients with atrial fibrillation or other recurrent arrhythmias.

Implantable Cardioverter-Defibrillators

An implantable cardioverter-defibrillator (ICD) is a device capable of detecting dangerous ventricular arrhythmias and delivering therapy automatically.

ICDs may provide:

• Defibrillation
• Cardioversion
• Backup pacing

Note: They may be used in patients who have survived ventricular tachycardia or ventricular fibrillation or in selected patients who are at high risk of recurrent life-threatening ventricular arrhythmias.

Importance of Treating the Patient, Not Just the ECG

ECG interpretation is only one part of arrhythmia assessment. The same rhythm may have very different clinical consequences depending on the patient’s cardiac function, blood pressure, oxygenation, and underlying disease.

A patient with an abnormal rhythm should be assessed for:

• Pulse
• Blood pressure
• Mental status
• Oxygen saturation
• Respiratory distress
• Chest discomfort
• Peripheral perfusion
• Skin temperature and appearance
• Signs of reduced cardiac output

Note: This principle is especially important in pulseless electrical activity, where the ECG may appear organized even though the patient has no effective circulation.

Arrhythmia Practice Questions

1. What is an arrhythmia?
An arrhythmia is an abnormality in the heart’s rate, rhythm, origin of electrical impulses, or conduction through the cardiac conduction system.

2. What is the normal resting heart rate for an adult in normal sinus rhythm?
The normal resting heart rate for an adult in normal sinus rhythm is 60 to 100 beats/min.

3. What structure normally initiates the electrical impulse that produces normal sinus rhythm?
The sinoatrial (SA) node normally initiates the electrical impulse that produces normal sinus rhythm.

4. What is the normal PR interval on an ECG?
The normal PR interval is 0.12 to 0.20 second.

5. What is the normal duration of the QRS complex?
The normal QRS duration is 0.12 second or less.

6. What ECG relationship should be present between P waves and QRS complexes during normal sinus rhythm?
Each P wave should be followed by a QRS complex, and each QRS complex should be preceded by a P wave.

7. What is sinus tachycardia?
Sinus tachycardia is a sinus rhythm with a resting heart rate greater than 100 beats/min in an adult while normal atrial-to-ventricular conduction is maintained.

8. What are common causes of sinus tachycardia?
Common causes of sinus tachycardia include hypoxemia, fever, pain, anxiety, hypovolemia, hypotension, increased metabolic activity, and certain medications.

9. How is sinus tachycardia usually managed?
Sinus tachycardia is usually managed by identifying and correcting its underlying cause rather than treating the increased heart rate alone.

10. What is sinus bradycardia?
Sinus bradycardia is a sinus rhythm with a heart rate below 60 beats/min in an adult while the electrical impulse continues to originate from the SA node.

11. Why may sinus bradycardia be normal in a well-conditioned athlete?
A well-conditioned athlete may have sinus bradycardia because an increased stroke volume allows adequate cardiac output to be maintained at a slower heart rate.

12. When can sinus bradycardia become clinically significant?
Sinus bradycardia becomes clinically significant when the slow heart rate reduces cardiac output and produces symptoms or signs of inadequate tissue perfusion.

13. What treatments may be considered for symptomatic sinus bradycardia?
Symptomatic sinus bradycardia may be treated with atropine, correction of the underlying cause, or cardiac pacing when necessary.

14. What is sinus arrhythmia?
Sinus arrhythmia is a sinus rhythm in which the heart rate varies, commonly in association with the respiratory cycle, while the remaining ECG characteristics are generally normal.

15. What happens to the heart rate during normal respiratory sinus arrhythmia?
The heart rate generally increases during inspiration and decreases during expiration.

16. What is atrial flutter?
Atrial flutter is an atrial arrhythmia characterized by rapid, organized atrial electrical activity, commonly at a rate of approximately 250 to 350 beats/min.

17. What characteristic ECG appearance is associated with atrial flutter?
Atrial flutter commonly produces characteristic sawtooth flutter waves between QRS complexes.

18. Why does every atrial impulse not reach the ventricles during atrial flutter?
The AV node prevents every rapidly occurring atrial impulse from being conducted to the ventricles, resulting in conduction patterns such as 2:1, 3:1, or 4:1.

19. What is atrial fibrillation?
Atrial fibrillation is an arrhythmia caused by disorganized electrical activity from multiple atrial sites, resulting in ineffective atrial contraction and an irregular ventricular rhythm.

20. What are the characteristic ECG findings of atrial fibrillation?
Atrial fibrillation is characterized by absent normal P waves, fibrillatory atrial activity, and irregular R-R intervals.

21. Why does atrial fibrillation increase the risk of thrombus formation?
Atrial fibrillation prevents coordinated atrial contraction and complete atrial emptying, allowing blood to stagnate and potentially form thrombi.

22. What is first-degree AV block?
First-degree AV block is delayed conduction from the atria to the ventricles characterized by a PR interval greater than 0.20 second while every P wave is still followed by a QRS complex.

23. What ECG pattern identifies Mobitz type I second-degree AV block?
Mobitz type I second-degree AV block is identified by progressive lengthening of the PR interval until a P wave is not followed by a QRS complex.

24. How does Mobitz type II second-degree AV block differ from Mobitz type I?
In Mobitz type II, occasional P waves are not followed by QRS complexes without progressive PR interval lengthening before the dropped beats.

25. What is third-degree AV block?
Third-degree AV block, or complete heart block, occurs when atrial impulses no longer conduct to the ventricles, causing the atria and ventricles to beat independently under separate pacemakers.

26. What is a premature ventricular contraction (PVC)?
A premature ventricular contraction is an early heartbeat that originates from an abnormal electrical focus within the ventricles rather than from the normal conduction system.

27. What ECG finding is typical of a PVC?
A PVC typically appears as a premature, wide, and abnormal QRS complex that differs from the patient’s normal ventricular complexes.

28. Is a normal P wave usually present immediately before a PVC?
No. A normal P wave is generally absent immediately before a PVC because the impulse originates within the ventricles.

29. What is a compensatory pause after a PVC?
A compensatory pause is the longer interval that often follows a premature ventricular contraction before the next normal heartbeat occurs.

30. What does the presence of multifocal PVCs suggest?
Multifocal PVCs suggest that more than one area of the ventricles is electrically irritable.

31. What is the R-on-T phenomenon?
The R-on-T phenomenon occurs when a PVC falls early on the preceding T wave during ventricular repolarization.

32. Why is the R-on-T phenomenon clinically important?
The R-on-T phenomenon is important because it may trigger a dangerous ventricular arrhythmia such as ventricular tachycardia.

33. What is ventricular tachycardia?
Ventricular tachycardia is a rapid ventricular rhythm generally defined as three or more consecutive ventricular beats originating from the ventricles.

34. Why can ventricular tachycardia reduce cardiac output?
Ventricular tachycardia can reduce cardiac output because the ventricles contract so rapidly that there is insufficient time for adequate ventricular filling.

35. What is the first clinical assessment that should be made when ventricular tachycardia is identified?
The clinician should immediately determine whether the patient has a pulse and effective circulation.

36. How may unstable ventricular tachycardia with a pulse be treated?
Unstable ventricular tachycardia with a pulse may require synchronized cardioversion.

37. How is pulseless ventricular tachycardia treated?
Pulseless ventricular tachycardia is treated as cardiac arrest with immediate CPR and defibrillation.

38. What is ventricular flutter?
Ventricular flutter is an extremely rapid and unstable ventricular rhythm with poorly defined QRS complexes that can quickly deteriorate into ventricular fibrillation.

39. What is ventricular fibrillation?
Ventricular fibrillation is chaotic ventricular electrical activity that prevents coordinated ventricular contraction and eliminates effective cardiac output.

40. Why is ventricular fibrillation considered a cardiac-arrest rhythm?
Ventricular fibrillation is considered a cardiac-arrest rhythm because the ventricles do not produce an effective mechanical contraction, leaving the patient without a pulse or meaningful circulation.

41. What is the immediate treatment priority for ventricular fibrillation?
The immediate priorities are high-quality CPR and rapid defibrillation.

42. What is pulseless electrical activity (PEA)?
Pulseless electrical activity is a condition in which organized electrical activity appears on the ECG but no palpable pulse or effective mechanical cardiac output is present.

43. Why does PEA demonstrate the importance of assessing the patient rather than only the ECG monitor?
PEA shows that visible electrical activity does not necessarily mean the heart is producing an effective mechanical contraction or adequate circulation.

44. Is pulseless electrical activity a shockable rhythm?
No. Pulseless electrical activity is a nonshockable cardiac-arrest rhythm.

45. What is asystole?
Asystole is the absence of effective ventricular electrical activity and is associated with cardiac arrest.

46. Is asystole treated with routine defibrillation?
No. Asystole is a nonshockable rhythm that requires CPR and evaluation for reversible causes.

47. How can hypoxemia contribute to arrhythmias?
Hypoxemia can irritate the myocardium and alter cardiac electrical activity, contributing to tachycardia, PVCs, and more serious arrhythmias.

48. How can hypokalemia affect the ECG?
Hypokalemia can contribute to arrhythmias and may produce ST-segment depression, flattened or inverted T waves, and prominent U waves.

49. What ECG changes may occur with hyperkalemia?
Hyperkalemia may produce tall T waves and widening of the QRS complex.

50. Why should electrolyte levels be evaluated in a patient with an unexplained arrhythmia?
Electrolytes should be evaluated because abnormalities in potassium, calcium, and other ions can disrupt myocardial depolarization, repolarization, and conduction.

51. What is paroxysmal atrial tachycardia?
Paroxysmal atrial tachycardia is a rapid atrial rhythm that originates from an abnormal atrial focus and consists of three or more consecutive premature atrial impulses.

52. What heart rate range is commonly associated with paroxysmal atrial tachycardia?
Paroxysmal atrial tachycardia commonly produces a heart rate of approximately 140 to 250 beats/min.

53. What symptoms may occur during paroxysmal atrial tachycardia?
Symptoms may include palpitations, chest fluttering, weakness, shortness of breath, and angina.

54. What treatment options may be used for paroxysmal atrial tachycardia?
Treatment may include vagal stimulation, medications that slow the heart rate or conduction, and synchronized cardioversion when necessary.

55. What is a premature atrial contraction (PAC)?
A premature atrial contraction is an early heartbeat that originates from an abnormal focus within the atria.

56. What is atrial bigeminy?
Atrial bigeminy is a repeating rhythm pattern in which every normal beat is followed by a premature atrial contraction.

57. What does a prolonged PR interval suggest?
A prolonged PR interval suggests delayed conduction through the atrioventricular conduction system.

58. What is the key difference between first-degree and second-degree AV block?
In first-degree AV block, every atrial impulse reaches the ventricles, while in second-degree AV block, some atrial impulses fail to conduct.

59. Why is Mobitz type II considered more serious than Mobitz type I?
Mobitz type II is more serious because it reflects greater conduction-system disease and may progress to complete heart block.

60. What happens to atrial and ventricular activity during complete heart block?
The atria and ventricles beat independently because atrial impulses no longer conduct to the ventricles.

61. What ventricular rate may occur when the escape rhythm originates near the bundle of His during complete heart block?
The ventricular rate may be approximately 40 to 60 beats/min.

62. What ventricular rate may occur when the escape rhythm originates lower in the ventricles during complete heart block?
The ventricular rate may fall to approximately 20 to 40 beats/min.

63. Why can complete heart block cause syncope?
Complete heart block can cause syncope because the slow ventricular escape rhythm may reduce cardiac output and cerebral perfusion.

64. What does a QRS duration greater than 0.12 second suggest?
A QRS duration greater than 0.12 second may indicate abnormal ventricular conduction, such as a PVC, bundle branch block, ventricular tachycardia, or hyperkalemia.

65. What can a prolonged QT interval indicate?
A prolonged QT interval may be associated with myocardial ischemia, electrolyte disturbances, antiarrhythmic medications, or certain antidepressants.

66. Why are antiarrhythmic drugs capable of causing proarrhythmia?
Antiarrhythmic drugs alter cardiac electrical activity and can sometimes create or worsen abnormal rhythms while treating another arrhythmia.

67. What is the primary action of Class I antiarrhythmic medications?
Class I antiarrhythmic medications primarily block fast sodium channels and affect myocardial depolarization.

68. Which antiarrhythmic drug is commonly used intravenously for ventricular arrhythmias?
Lidocaine is commonly used intravenously for ventricular arrhythmias.

69. What are Class II antiarrhythmic medications?
Class II antiarrhythmic medications are beta blockers that reduce sympathetic stimulation, slow the heart rate, and decrease AV-node conduction.

70. What respiratory adverse effect can occur with beta-blocking antiarrhythmic drugs?
Beta blockers can cause bronchoconstriction, which is especially important in patients with asthma or other bronchospastic disease.

71. What is the primary electrophysiologic effect of Class III antiarrhythmic drugs?
Class III antiarrhythmic drugs primarily prolong repolarization and the cardiac action potential.

72. Which Class III antiarrhythmic is commonly used for both supraventricular and ventricular arrhythmias?
Amiodarone is commonly used for both supraventricular and ventricular arrhythmias.

73. How do Class IV antiarrhythmic drugs affect cardiac conduction?
Class IV antiarrhythmic drugs slow conduction through the AV node by blocking calcium channels.

74. What is adenosine commonly used to treat?
Adenosine is commonly used to terminate certain supraventricular tachycardias.

75. Why must adenosine be administered rapidly?
Adenosine must be administered rapidly because it has an extremely short half-life and its effects last only a brief period.

76. What is synchronized cardioversion?
Synchronized cardioversion is the delivery of an electrical shock timed to the cardiac cycle to treat certain unstable tachyarrhythmias in patients who still have a pulse.

77. What is defibrillation?
Defibrillation is the delivery of an unsynchronized electrical shock to terminate life-threatening ventricular arrhythmias such as ventricular fibrillation and pulseless ventricular tachycardia.

78. What is radiofrequency catheter ablation?
Radiofrequency catheter ablation is a procedure that destroys a small area of cardiac tissue responsible for generating or maintaining an abnormal electrical rhythm.

79. What is an implantable cardioverter-defibrillator (ICD)?
An implantable cardioverter-defibrillator is a device that detects dangerous ventricular arrhythmias and can provide defibrillation, cardioversion, and backup pacing.

80. Which patients may benefit from an implantable cardioverter-defibrillator?
Patients who have survived ventricular tachycardia or ventricular fibrillation or who are at high risk for recurrent life-threatening ventricular arrhythmias may benefit from an ICD.

81. How can positive-pressure ventilation contribute to cardiovascular instability?
Positive-pressure ventilation can increase intrathoracic pressure, reduce venous return, and contribute to decreased cardiac output and hypotension.

82. Why can an arrhythmia during mechanical ventilation be clinically important?
An arrhythmia during mechanical ventilation may indicate broader cardiopulmonary instability involving oxygenation, ventilation, blood pressure, cardiac output, or perfusion.

83. How can prolonged endotracheal suctioning affect the heart rhythm?
Prolonged endotracheal suctioning can contribute to hypoxemia, bradycardia, and arrhythmias.

84. Why should cardiac rhythm be monitored during endotracheal suctioning?
Cardiac rhythm should be monitored because suctioning can produce rapid changes in oxygenation and autonomic activity that may trigger clinically significant rhythm disturbances.

85. Why can an arrhythmia interfere with ventilator weaning?
An arrhythmia can reduce cardiac output and limit the cardiovascular reserve needed to meet the increased oxygen demands of spontaneous breathing.

86. What does the development of an arrhythmia during a spontaneous breathing trial suggest?
An arrhythmia during a spontaneous breathing trial may indicate that the patient is not tolerating the increased physiologic workload.

87. What other findings may accompany intolerance of a spontaneous breathing trial?
Findings may include tachypnea, tachycardia, hypoxemia, hypertension, hypotension, acidosis, agitation, diaphoresis, and increased work of breathing.

88. Why should an important arrhythmia be controlled before extubation?
An important arrhythmia may indicate inadequate cardiopulmonary stability and increase the risk that the patient will not tolerate the transition to independent breathing.

89. What percentage of newborns may demonstrate an abnormal heart rate or rhythm during the first few days of life?
Approximately 1% to 5% of newborns may demonstrate some form of abnormal heart rate or rhythm.

90. What is the approximate normal heart rate range for a newborn?
The normal neonatal heart rate is generally about 120 to 170 beats/min, although normal variation can occur with sleep, activity, pain, and illness.

91. Why may premature atrial contractions in newborns not require treatment?
Premature atrial contractions in newborns are often transient and benign and may resolve without specific therapy.

92. Why is bradycardia in a premature infant often associated with respiratory problems?
Bradycardia in a premature infant may accompany apnea and hypoxemia caused by immature respiratory control.

93. What diagnostic test is useful when a newborn has severe unexplained tachycardia or bradycardia?
An electrocardiogram is useful for identifying the source and pattern of severe unexplained tachycardia or bradycardia.

94. What additional problems should be considered when evaluating neonatal arrhythmias?
Possible contributing problems include hypoxemia, sepsis, electrolyte abnormalities, acid-base disturbances, congenital heart disease, and metabolic disorders.

95. How can a central venous catheter cause an arrhythmia?
A central venous catheter advanced too close to or into cardiac structures can mechanically irritate the myocardium and trigger an abnormal rhythm.

96. Why is radiographic confirmation of central venous catheter position important in neonates and children?
Radiographic confirmation helps ensure that the catheter tip is appropriately positioned and reduces the risk of complications such as cardiac irritation and arrhythmias.

97. How does severe hypothermia affect cardiac rhythm?
Severe hypothermia can cause marked bradycardia, prolonged conduction intervals, ventricular arrhythmias, ventricular fibrillation, and cardiac arrest.

98. Why should a severely hypothermic patient be handled carefully?
The cold myocardium can become highly irritable, and excessive movement may trigger a dangerous arrhythmia such as ventricular fibrillation.

99. What effect does digoxin have on AV-node conduction?
Digoxin slows conduction through the AV node and increases vagal influence on the heart, which can help reduce the ventricular rate in selected patients.

100. Why must the patient’s clinical condition always be assessed along with the ECG?
The ECG shows electrical activity, but only direct clinical assessment can determine whether the patient has an effective pulse, adequate blood pressure, sufficient oxygenation, and acceptable tissue perfusion.

Final Thoughts

Arrhythmias range from relatively harmless variations in sinus rhythm to life-threatening disturbances such as ventricular tachycardia and ventricular fibrillation. Recognition begins with a systematic understanding of normal sinus rhythm and careful evaluation of heart rate, regularity, P waves, PR intervals, QRS complexes, and atrial-ventricular relationships.

Clinicians must also identify underlying causes such as hypoxemia, electrolyte abnormalities, medications, myocardial disease, or respiratory instability.

Most importantly, the ECG should never be interpreted in isolation. Effective arrhythmia management requires assessment of the patient’s circulation, oxygenation, blood pressure, symptoms, and overall clinical condition.